A pan-cancer proteomic perspective on The Cancer Genome Atlas R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... Nature communications 5 (1), 3887, 2014 | 547 | 2014 |
ℓ1-penalization for mixture regression models N Städler, P Bühlmann, S Van De Geer Test 19, 209-256, 2010 | 369 | 2010 |
Missing values: sparse inverse covariance estimation and an extension to sparse regression N Städler, P Bühlmann Statistics and Computing 22, 219-235, 2012 | 115 | 2012 |
Pattern alternating maximization algorithm for missing data in high-dimensional problems. N Städler, DJ Stekhoven, P Bühlmann J. Mach. Learn. Res. 15 (1), 1903-1928, 2014 | 34 | 2014 |
Penalized estimation in high-dimensional hidden Markov models with state-specific graphical models N Städler, S Mukherjee The Annals of Applied Statistics, 2157-2179, 2013 | 31 | 2013 |
Bivariate network meta‐analysis for surrogate endpoint evaluation S Bujkiewicz, D Jackson, JR Thompson, RM Turner, N Städler, ... Statistics in medicine 38 (18), 3322-3341, 2019 | 30 | 2019 |
Bayesian hierarchical meta‐analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data T Papanikos, JR Thompson, KR Abrams, N Städler, O Ciani, R Taylor, ... Statistics in medicine 39 (8), 1103-1124, 2020 | 24 | 2020 |
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study N Städler, F Dondelinger, SM Hill, R Akbani, Y Lu, GB Mills, S Mukherjee Bioinformatics 33 (18), 2890-2896, 2017 | 20 | 2017 |
Multivariate gene-set testing based on graphical models N Städler, S Mukherjee Biostatistics 16 (1), 47-59, 2015 | 17 | 2015 |
A pan-cancer proteomic perspective on the cancer genome atlas. Nat Commun. 2014; 5: 3887 R Akbani, PK Ng, HM Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... Epub 2014/05/30. https://doi. org/10.1038/ncomms4887 PMID: 24871328 6, 4852, 0 | 17 | |
Two-sample testing in high dimensions N Städler, S Mukherjee Journal of the Royal Statistical Society Series B: Statistical Methodology …, 2017 | 16 | 2017 |
A systematic review and network meta-analysis to evaluate the comparative efficacy of interventions for unfit patients with chronic lymphocytic leukemia N Städler, A Shang, F Bosch, A Briggs, V Goede, A Berthier, C Renaudin, ... Advances in therapy 33, 1814-1830, 2016 | 16 | 2016 |
High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis S Fuchs, N Sawas, N Staedler, DA Schubert, A D'Andrea, R Zeiser, L Piali, ... European journal of immunology 49 (3), 462-475, 2019 | 13 | 2019 |
Pattern alternating maximization algorithm for high-dimensional missing data N Städler, P Bühlmann Arxiv preprint arXiv 1005, 2010 | 12 | 2010 |
Multi-sensor data fusion for non-invasive continuous glucose monitoring D Huber, N Stadler, L Falco-Jonasson, M Talary, W Stahel, F Dewarrat, ... Information Fusion, 2007 10th International Conference on, 1-10, 2007 | 12 | 2007 |
Correction: Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... Nature communications 6 (1), 4852, 2015 | 10 | 2015 |
291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors F Barlesi, M Lolkema, KS Rohrberg, C Hierro, A Marabelle, AA Razak, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 9 | 2020 |
Two-sample testing in high-dimensional models N Städler, S Mukherjee arXiv preprint arXiv:1210.4584, 2012 | 9 | 2012 |
Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer EG Elia, N Städler, O Ciani, RS Taylor, S Bujkiewicz Cancer Epidemiology 64, 101665, 2020 | 8 | 2020 |
A pan-cancer proteomic perspective on the Cancer Genome Atlas. Nat Commun 5: 3887 R Akbani, PK Ng, HM Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ... | 5 | 2014 |